Clinical trial
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis in Transition From Interferon to Glatiramer Acetate (Copaxone®)
NCT01111435 is registered in ClinicalTrials.gov with Fraser, Cira, Ph.D., RN, ACNS-BC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Spasticity in Individuals With Multiple Sclerosis in Transition From Interferon to Glatiramer Acetate (Copaxone®)
- Lead sponsor
- Fraser, Cira, Ph.D., RN, ACNS-BC
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity